key: cord-0930887-titqjxgj authors: Galindo-Villegas, Jorge title: The Zebrafish Disease and Drug Screening Model: A Strong Ally Against Covid-19 date: 2020-05-01 journal: Front Pharmacol DOI: 10.3389/fphar.2020.00680 sha: 90ec19dcc701bdc88a5631edf5d6f12022554ae2 doc_id: 930887 cord_uid: titqjxgj nan Animal models of human diseases have proven effective in the screening of pharmacological drugs and in further determining the specific therapeutic targets in humans. Therefore, a collection of reliable animal models that replicates the Covid-19 clinical symptoms is urgently needed in order to decipher the transmission route and pathobiology of the disease. Among the available model candidates, a wide selection exists with murine models on top of the list (Callaway, 2020) . However, a handy vertebrate, the zebrafish, emerges as an outstanding and specific poised model for the screening of novel therapeutics and chemical modifiers of biological processes in vivo. The zebrafish is an extremely versatile organism that, following proper automated settings, can be visually inspected using transmitted light or fluorescent imaging. At the same time, the signaling pathways, chemical interactions, and physical forces that regulate the development and progress of the host-virus interactions on mucosal tissues are amenable to analysis with exquisite detail. Indeed, the process of chemical throughput screening using the full organism is simple. The early developmental stages behave in a well-plate similarly to the cells used in must laboratories practicing in vitro testing approaches with pharmacological drugs. As a matter of support, it is worth noting that no matter the physiological differences, 84% of human genes associated with the specific disease have a counterpart in zebrafish, and the crosstalk of viral glycoproteins at the fish nasal neuro-immune edge are understood (Sepahi et al., 2019) . Therefore, reliable projections suggest that employing zebrafish for analyses may provide faster, more accurate, reliable, and holistic responses compared with single-cell entities. Several human viruses colonize zebrafish, such as Sindbis, chikungunya, and influenza A, as well as a variety of airborne bacteria and fungi (Gomes and Mostowy, 2020) . A variety of mycobacteria affecting humans have been studied using this model on a level 3 biosecurity facility. Tuberculosis pathogenesis is a sound example, and the infection is established in zebrafish larvae using Mycobacterium marinum (a close relative of Mycobacterium tuberculosis), then screened in vivo by real-time fluorescent microscopy and automated plate fluorometry (Takaki et al., 2013) . Infection clearance was achieved following an in vivo screening of large chemical libraries on 96-well microplates, with only 0.1 µmol of drug per fish. Among the drugs recently proposed for use against Covid-19 (Gordon et al., 2020) , metformin (Met) has been suggested. Potentially beneficial effects of Met on cellular metabolism, immune function, and gene transcription involved in innate host responses to Mycobacterium tuberculosis pathogenesis has been successfully screened, linking the core of radially arranged microtubules at the axoneme of variated human respiratory diseases with the zebrafish. No matter how severe the impact of Covid-19 is, the association of the incredible medical power in several profoundly impacted nations possessing zebrafish facilities working together with world-top scientists (like those at the Boston Children Hospital in the USA, Karlsruhe Institut für Technologie in Germany, Hospital for Sick Children in Canada, Regenerative Medicine Institute in Australia, Western General Hospital in the UK, or Hospital Universitario Virgen de la Arrixaca in Spain) with cutting-edge technology and full capacities in the use, the application of the above-described zebrafish techniques could provide novel results soon. We face a huge public health emergency (Song and Karako, 2020) , thus, the sole intention of this perspective is to urgently inspire the medical community to explore the compound effect and associated molecular mechanisms of the proposed pharmacological drugs on this alternative approach committed toward fighting the pandemic. JG-V designed, drafted, and submitted the full document. The author acknowledge the publishing financial support obtained through Frontiers Media COVID Open Access Fund. Labs rush to study coronavirus in transgenic animals -some are in short supply The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial The case for modeling human infection in zebrafish A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing The potential danger of suboptimal antibody responses in COVID-19 Coronavirus disease 2019 (COVID-19): situation report, 92. World Health Organization Olfactory sensory neurons mediate ultrarapid antiviral immune responses in a TrkA-dependent manner COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafish